Opus Genetics (IRD) Reiterated at Overweight by Cantor Fitzgerald on Positive Update
Tweet Send to a Friend
Cantor Fitzgerald analyst Steve Seedhouse reiterated an Overweight rating and $15.00 price target on Opus Genetics (NASDAQ: IRD).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
